The UV Index was established more than 20 years ago as a tool for sun protection and health care. Shortly after its introduction, UV Index monitoring started in several countries either by newly acquired instruments or by converting measurements from existing instruments into the UV Index. The number of stations and networks has increased over the years. Currently, 160 stations in 25 European countries deliver online values to the public via the Internet. In this paper an overview of these UV Index monitoring sites in Europe is given. The overview includes instruments as well as quality assurance and quality control procedures. Furthermore, some examples are given about how UV Index values are presented to the public. Through these efforts, 57% of the European population is supplied with high quality information, enabling them to adapt behaviour. Although health care, including skin cancer prevention, is cost-effective, a proportion of the European population still doesn't have access to UV Index information.
Overexposure to ultraviolet (UV) radiation is the main modifiable risk factor for skin cancer. The Global Solar Ultraviolet Index (UVI) was introduced as a tool to visualize the intensity of UV radiation on a certain day, which should enable and encourage people to take appropriate protective measures. The ‘low’ exposure category of the UVI, defined by a rounded UVI value of 0, 1 or 2, was linked to the health message ‘No protection required’ by the World Health Organization and partner organizations. However, published evidence corroborating this advice is not available. To evaluate the erythemal risk of low UVI days, we analyzed 14,431 daily time series of ambient erythemal irradiance data measured at nine stations of the German solar UV monitoring network during the years 2007–2016. We analyzed the proportion of days in the sample for which ambient erythemal doses calculated for various time intervals exceed average minimal erythemal doses (MEDs) of the Fitzpatrick skin phototypes I–VI to assess the potential for erythema arising from sun exposure on days with low UVI values. Additionally, we calculated for each day the minimum exposure duration needed to receive one MED. Our results indicate that on days with a UVI value of 0, risk of erythema is indeed negligible. Conversely, the abovementioned health message appears misleading when melano-compromised individuals (skin type I and II) spend more than 1.5 hours outdoors on days with a UVI value of 2. Under rare circumstances of prolonged exposure, MEDs of the two most sensitive skin types can also be exceeded even on days with a UVI value of 1. Hence, current WHO guidance for sun protection on days with low UVI values needs reconsideration.
Abstract. In late May 2005 unusual high levels of solar ultraviolet radiation were observed over central Europe. In Northern Germany the measured irradiance of erythemally effective radiation exceeded the climatological mean by more than about 20%. An extreme low ozone event for the season coincided with high solar elevation angles and high pressure induced clear sky conditions leading to the highest value of erythemal UV-radiation ever observed over this location in May since 1994. This hereafter called "ozone mini-hole" was caused by an elevation of tropopause height accompanied with a poleward advection of ozone-poor air from the tropics. The resultant increase in UV-radiation is of particular significance for human health. Dynamically induced low ozone episodes that happen in late spring can considerably enhance the solar UV-radiation in mid latitudes and therefore contribute to the UV-burden of people living in these regions.
Abstract. The detection of cloudiness is investigated by means of partial and total cloud amount estimations from pyrgeometer radiation measurements and visible all-sky imager observations. The measurements have been performed in Westerland, a seaside resort on the North Sea island of Sylt, Germany, during summer 2005.An improvement to previous studies on this subject resulting in the first time partial cloud amounts (PCAs), defined as cloud amounts without high clouds calculated from longwave downward radiation (LDR) according to the AP-CADA algorithm (Dürr and Philipona, 2004), are validated against both human observations from the National Meteorological Servive DWD at the nearby airport of Sylt and digital all-sky imaging. The aim is to establish the APCADA scheme at a coastal midlatitude site for longterm observations of cloud cover and to quantify errors resulting from the different methods of detecting cloudiness.Differences between the resulting total cloud amounts (TCAs), defined as cloud amount for all-cloud situations, derived from the camera images and from human observations are within ±1 octa in 72% and within ±2 octa in 85% of the cases. Compared to human observations, PCA measurements, according to APCADA, underestimate the observed cloud cover in 47% of all cases and the differences are within ±1 octa in 60% and ±2 octa in 74% of all cases. Since high cirrus clouds can not be derived from LDR, separate comparisons for all cases without high clouds have been performed showing an agreement within ±1(2) octa in 73(90)% for PCA and also for camera-derived TCA. For this coastal mid-latitude site under investigation, we find similar Correspondence to: A. Macke (amacke@ifm-geomar.de) though slightly smaller agreements to human observations as reported by Dürr and Philipona (2004). Though limited to daytime, the cloud cover retrievals from the sky imager are not really affected by cirrus clouds and provide a more reliable cloud climatology for all-cloud conditions than AP-CADA.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.